Letrozole
CAS number： 112809-51-5
Molecular formula： C17H11N5
molecular weight： 285.31
Chemical structure：
Producers shown on SFDA
(Record date:06/09/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Venturepharm (Hainan) Co., Ltd. | GMP | Valid till December 2022 |
Jiangsu Hengrui Medicine Co.,Ltd. | GMP | Valid till November 2024 |
Zhejiang Hisun Pharmaceutical Co., Ltd. | GMP | Valid till November 2024 |
Producers shown on EP
(Quoted from EP website；record date:06/09/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Letrozole | FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani | R1-CEP 2007-338-Rev 01 | 07/04/2020 | VALID | / | Chemistry |
| Letrozole | SCINOPHARM TAIWAN, LTD. TW 74144 Shan-Hua | R1-CEP 2008-127-Rev 02 | 04/04/2019 | VALID | / | Chemistry |
| Letrozole | SHILPA MEDICARE LIMITED IN 584 135 Raichur | R1-CEP 2013-321-Rev 00 | 12/05/2020 | VALID | / | Chemistry |
| Letrozole | APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore | R0-CEP 2011-066-Rev 00 | 24/05/2013 | EXPIRED | 29/05/2018 | Chemistry |
| Letrozole | DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad | R1-CEP 2008-280-Rev 01 | 30/04/2015 | VALID | / | Chemistry |
| Letrozole | HETERO LABS LIMITED IN 500 018 Hyderabad | R1-CEP 2012-145-Rev 01 | 14/03/2019 | VALID | / | Chemistry |
| Letrozole | Zhejiang Hisun Pharmaceutical Co., Ltd. CN 318 000 Taizhou City | R0-CEP 2010-331-Rev 01 | 14/09/2012 | WITHDRAWN BY HOLDER | 21/12/2020 | Chemistry |
| Letrozole | NATCO PHARMA LIMITED IN 500 034 Hyderabad | R1-CEP 2007-150-Rev 03 | 14/02/2017 | VALID | / | Chemistry |
| Letrozole | SYNTHON BV NL 6545 CM Nijmegen | R1-CEP 2010-269-Rev 01 | 25/10/2016 | VALID | / | Chemistry |
| Letrozole | Ind-Swift Laboratories Limited IN 160 101 Chandigarh | R1-CEP 2009-105-Rev 03 | 26/01/2021 | VALID | / | Chemistry |
| Letrozole | JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang | R1-CEP 2010-270-Rev 02 | 26/08/2019 | VALID | / | Chemistry |
| Letrozole | NOVARTIS PHARMA AG CH 4002 Basel | R0-CEP 2019-149-Rev 00 | 03/09/2020 | VALID | / | Chemistry |
| Letrozole | CIPLA LIMITED IN 400 013 Mumbai | R1-CEP 2010-300-Rev 00 | 08/07/2019 | VALID | / | Chemistry |
| Letrozole | MYLAN LABORATORIES LIMITED IN 500 096 Hyderabad | R1-CEP 2013-214-Rev 00 | 01/10/2019 | WITHDRAWN BY HOLDER | 16/09/2020 | Chemistry |
| Letrozole | MAC CHEM PRODUCTS (INDIA) PVT. LTD. IN 400 059 Mumbai | R1-CEP 2012-350-Rev 01 | 19/12/2019 | VALID | / | Chemistry |
| Letrozole | SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai | R1-CEP 2009-147-Rev 00 | 02/12/2015 | VALID | / | Chemistry |
Producer:Venturepharm (Hainan) Co., Ltd.,is a group providing outsourced production service management for global pharmaceutical enterprises, which is authorized and managed by venturepharm Group Inc.
With 7 advanced API and preparation production bases in Asia, the company provides comprehensive production outsourcing services for global pharmaceutical enterprises. Customers can obtain professional support and services from the early stage of product development to large-scale production. All production bases of vante have passed GMP certification, and two API production bases have passed FDA certification.
Staff size:100-199 persons
Registered capital:RMB 194 million 870 thousand and 600
Producer:Jiangsu Hengrui Medicine Co.,Ltd. is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs.
The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan.
The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA.
Staff size:About 30000 persons
Registered capital:RMB 6 billion 397 million
Producer:Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956. In 2000, Hisun issued A-shares in Shanghai stock exchange, but it continues to remain a state-owned enterprise. Hisun is one of the largest antibiotics and anti-tumor drug production bases in the country. It has won several titles, including first batch of innovative enterprises, national technology innovation demonstration enterprises, and "National Industrial Brand Demonstration Enterprise” of the Chinese Ministry of Industry and Information Technology.
Hisun began as a small chemical factory and entered the pharmaceutical field in the early 1970s. Since its founding over 60 years ago in 1956, Hisun has amassed a total asset worth of 21.8 billion RMB. While Hisun is primarily engaged in the R&D, manufacturing, and sales and marking of API and final dosage forms of chemical and biological drugs, its core business has extended to include branded generic drugs, biosimilarst and other innovative drugs.
Staff size:About 9000 persns
Registered capital:RMB 1 billion 169 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE